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Inhalation of urban pollutants elevates the circulating levels of the vasoactive peptides endothelin (ET)-1 and ET-3 in rats. This effect
could explain the association between episodic variations of urban pollutants and acute cardiopulmonary morbidity and mortality
documented in epidemiological studies. Because the lungs are the primary source of circulating ET-1 and the main site of clearance from
circulation, we investigated the response of endothelin system genes in the lungs of Fischer-344 rats after 4-h nose-only inhalation of 0.8 ppm
ozone plus 49 mg/m3 EHC-93 (Ottawa particles). The mRNA levels for preproET-1, preproET-3, endothelin-converting enzyme (ECE)-1,
and ET receptor subtypes A and B were determined at 2 h, and 1, 2, 3, 7, and 14 days after exposure. The pollutants induced preproET-1 and
ECE-1 (P< 0.05) after 2 h, consistent with the notion of increased synthesis and conversion of the peptide ET-1 in lung endothelial cells.
PreproET-3 mRNA was down-regulated at 2 h post-exposure (P< 0.05), and returned to control levels by 24 h, indicating that induction of
ET-3 in the lungs is not responsible for the sustained elevation of ET-3 in plasma reported after inhalation of pollutants. Our results indicate
that lung endothelin system genes respond rapidly and transiently to inhalation of urban pollutants, consistent with the dynamics of urban
pollutant health effects in the human population.
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Urban air pollution is known to cause cardiovascular and
respiratory morbidity and mortality in the human population
[1–5]. Individuals with chronic artery diseases and those
with congestive heart failure are at particularly high risk of
dying after an air pollution episode [2,3]. Acute cardiac
effects have been reported less than 3 h after increases of
ambient fine particulate matter concentrations [6]. Although
epidemiological studies have consistently indicated a signif-
icant association of air pollution with adverse health effects,
it is only recently that laboratory evidence on plausible
mechanisms of effects has begun to substantiate these trends.
For example, we have shown that inhalation of urban
particulate matter increases circulating levels of endothelin0925-4439/$ - see front matter. Crown Copyright D 2004 Published by Elsevier
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[7,8], and recent field work by others has confirmed that
urban pollution is associated with elevated ET-1 in humans
[9]. In addition to the hemodynamic changes documented
after inhalation of urban particles in rats [8] and humans [10],
instillation of urban particle suspensions in the lungs has
been shown to elevate ET-1 and enhance arrhythmia in a
myocardial infarction model [11] and to accelerate athero-
sclerosis in hyperlipidemic rabbits [12].
Endothelins are potent vasoconstrictor peptides involved
in the homeostatic regulation of vascular smooth muscle tone
[13]. The pulmonary endothelium is the main source of
circulating endothelin, as well as the principal site for
clearance of the peptide from circulation [14]. The endothe-
lin family is composed of three 21-amino acid isomers (ET-1,
ET-2, ET-3), each encoded by distinct genes (preproET-1,
preproET-2, and preproET-3) [15]. The synthesized pre-
proendothelin peptides are cleaved by specific endoproteases
to 38- to 41-amino-acid precursors (referred to as the big
endothelins) that are themselves cleaved by endothelin-B.V. All rights reserved.
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peptides [16]. Endothelins act through specific G-protein
coupled receptors, the ETA receptor and ETB receptor [17].
Binding of endothelins to ETA and ETB receptors on smooth
muscle cells leads to vasoconstriction, whereas binding to
ETB receptors on endothelial cells stimulates the release of
nitric oxide, leading to relaxation of smooth muscle cells and
vasodilation (reviewed in Ref. [18]). Endothelins have a very
short half-life (order of minutes) in plasma [19,20] and are
cleared from circulation in part through binding to the ETB
receptor in the caveolae of lung capillary endothelial cells
[17,21]. De novo synthesis of ETB receptors appears to be
required to maintain ETB receptor density at the cell surface
[17]. Binding of ET-1 to the ETB receptor of endothelial cells
results in internalization and targeting of the receptor–ligand
complex to the lysosome [17]. Since the ETB receptor does
not appear to be recycled to the cell surface, replacement of
ETB receptors requires transcriptional activation of the
cognate gene.
Increased circulating levels of ET-1 are associated with
many cardiovascular diseases, including congestive heart
failure, hypertension, and atherosclerosis (reviewed in Ref.
[22]). Increased pulmonary spill-over of ET-1 from up-
regulation of expression associated with decreased clearance
through down-regulation of lung capillary ETB receptor is
thought to be a fundamental change in the progression of
congestive heart failure [23,24]. Due to their important role
in the regulation of cardiovascular function and their in-
volvement in the pathogenesis of cardiovascular disease, an
alteration of circulating endothelin levels offers a plausible
biological mechanism to account for cardiovascular health
effects of urban pollutant inhalation. We propose that sus-
tained elevation of the steady-state plasma concentrations of
ET-1 and ET-3 levels following exposure to urban particulate
matter could result from at least three possible distinct effects
in the lungs, or any combination of those effects: (1) up-
regulation of the cognate genes, (2) increased rate of con-
version of the precursor peptide by elevated ECE expression
and activity, and (3) decreased clearance of the mature
endothelins from blood plasma through down-regulation of
the ETB receptor.
In a previous study, intratracheal instillation of 5-mg
EHC-93 (Ottawa urban particles) in saline into the lungs of
rats caused a decrease in lung ET-1 mRNA and angiotensin-
converting enzyme (ACE) mRNA, and an increase of
inducible nitric oxide synthase (iNOS) mRNA 48 h after
exposure [25]. The particles also increased tumour necrosis
factor (TNF)-a and macrophage inflammatory protein
(MIP)-2 in alveoli [25]. Down-regulation of ET-1 and
ACE is indicative of endothelial injury [26,27], and it is
possible that the down-regulation followed an earlier induc-
tion of the genes. To our knowledge, there are at present no
data on lung ET-1 mRNA in animals following inhalation of
urban pollutants. In order to gain a better understanding of
the relationship between pulmonary deposition of air pollu-
tants and regulation of the endothelin system genes, ratswere exposed by nose-only inhalation to ozone and the
urban particles EHC-93. The mRNA levels for ET-1, ET-3,
ECE-1, ETA receptor, and ETB receptor were examined over
the course of 14 days. Our results indicate that the lung
endothelin system responds to inhalation of urban pollutants
with a rapid and transient increase of mRNA for preproET-1
and ECE-1, consistent with the notion of increased rates of
de novo synthesis and conversion of the potent vasoactive
peptide ET-1. The data substantiate the biological basis for
the epidemiological association between air pollutants and
cardiovascular morbidity and mortality.2. Materials and methods
2.1. Animals
Fischer-344 adult male rats (200–250 g) were obtained
from Charles River in filter boxes at least 2 weeks prior to
the experiments (St. Constant, Que´bec, Canada). The ani-
mals were housed in individual plexiglass cages on wood-
chip bedding under HEPA-filtered air and a 12-h dark/light
cycle. Food and water were provided ad libitum. All
experimental protocols were reviewed by the Animal Care
Committee of Health Canada.
2.2. Respirable urban particulate matter
The urban ambient particles EHC-93 consist of total
suspended particulate matter recovered from filters of the
single-pass air-purification system of the Environmental
Health Centre at Tunney’s Pasture in Ottawa, Canada, and
cleaned through a 36-Am mesh to remove spores and debris.
The particles have a median physical diameter on the order
of 0.5 Am. The chemical composition, biological reactivity
of the particles in cell culture models, and applications in
inhalation studies have been described elsewhere
[7,8,28,29].
2.3. Inhalation exposures
Animals were exposed to ozone and EHC-93 urban
particles in a nose-only inhalation exposure system as
described previously [29]. The rats were trained in nose-
only exposure tubes over 5 consecutive days, and then
exposed once for 4 h to clean air or 0.8 ppm ozone plus
49 mg/m3 EHC-93. The particle size distribution of resus-
pended EHC-93 in our flow-past nose-only exposure system
is multimodal, with two respirable modes at 1.3-Am (aero-
dynamic diameter, DAE) and 3.6-Am DAE that together
contained 55% of the mass of the aerosol, and a non-
respirable mode at 15-Am DAE that contained 45% of the
mass [8]. Rats were euthanized by administration of sodium
pentobarbital (60 mg/kg i.p.) at 2 h, and 1, 2, 3, 7, and 14
days post-exposure. The lungs were rapidly excised, diced,
flash frozen in liquid nitrogen, and stored at  80 jC.
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Total RNA was isolated from frozen lung samples using
the TRIzol reagent (Invitrogen Canada Inc., Burlington,
Ontario, Canada) according to the manufacturer’s instruc-
tions at a ratio of 0.2 g tissue/1.5 ml TRIzol. The resulting
RNA pellet was air-dried, resuspended in RNase-free Tris–
EDTA buffer, and frozen at  80 jC. Total RNA concen-
tration was determined at 260 nm using a Spectronic
photodiode array spectrophotometer (Milton Roy, Rockford,
IL, USA).
2.5. Reverse transcription/polymerase chain reaction
(RT/PCR)
The following primer sequences for preproET-1, pre-
proET-3, ECE-1, ETA receptor, ETB receptor [30] and h-
actin [31] were used:ET-1 forward 5V-GCTCCTGCTCCTCCTTGATG-3V
ET-3 forward 5V-GCACTTGCTTCACTTATAAGG-3V
ECE-1 forward 5V-CGTAGCGATAGTCTTAGCAC-3V
ETA forward 5V-TTCGTCATGGTACCCTTCGA-3V
ETB forward 5V- TTCACCTCAGCAGGATTCTG-3V
h-Actin forward 5V-CTGATCCACATCTGCTGGAAGGTGG-3
Fig. 1. Composite fluorescence image (SYBR Green I) of RT-PCR products for the
as a function of number of cycles. One major product was observed for each prim
quantification at early to mid-exponential phase of the amplification.RT-PCR was carried out on a Thermolyne Amplitron II
Thermal Cycler (Barnstead Thermolyne, Dubuque, IA,
USA) using GeneAmp reagents (Applied Biosystems, Mis-
sissauga, Ontario, Canada). The reverse transcription reac-
tion mix consisted of 5 mM MgCl2, 1 PCR buffer II, 1
mM each dNTP, 1 unit/Al RNase inhibitor, 2.5 units/
Al MuLV reverse transcriptase and 2.5 AM random hexam-
ers. Six hundred (600) nanograms of total RNAwas used in
each reaction. Reverse transcription was carried out at 42 jC
for 45 min, 99 jC for 5 min, and 5 jC for 5 min. The PCR
reaction mix consisted of 2 mM MgCl2, 1 PCR buffer II,
1.25 units/reaction AmpliTAQ gold polymerase and 0.5 AM
of each primer. PCR cycling involved a hot start at 95 jC for
10 min, followed by 25 cycles of the following: 95 jC for 1
min (denaturation); 50 jC for 1 min (annealing); and 72 jC
for 1 min (extension). PCR reactions were stopped in early–
mid log phase, well before the plateau phase of the reaction
(Fig. 1).reverse 5V-CTCGCTCTATGTAAGTCATGG-3V
reverse 5V-CAGAAGCAAGAAGCATCAGTTG-3V
reverse 5V-GTGCCACACCAAAACTACAG-3V
reverse 5V-GATACTCGTTCCATTCATGG-3V
reverse 5V-AGGTGTGGAAAGTTAGAACG-3V
V reverse 5V-ACCTTCAACACCCCAGCCATGTACG-3V2.6. Visualization of the PCR products
PCR products were separated by electrophoresis on 1%
agarose gels containing 1:10000 dilution of SYBR Green I
(Molecular Probes, Eugene, OR) for 1 h at an applied
voltage of 80 V. After electrophoresis, gels were scanned
with a Storm 840 (Amersham BioSciences, Baie D’ Urfe´,
Que´bec, Canada) and the band intensities were quantified
using the ImageQuant software package (Molecular Devi-
ces, Sunnyvale, CA, USA). The expression of each gene of
interest was normalized to h-actin expression.
2.7. Dose modeling
Deposition of particles in our experimental animals and
for a plausible human-exposure scenario were calculatedusing the Multiple Path Particle Deposition software
(MPPDep v1.11, RIVM Publications, Bilthoven, The Neth-
erlands) essentially as described before [8]. Model assump-
tions for rats were a tidal volume of 2.1 ml, a breathing
frequency of 102 min 1, strict nasal breathing, and an
alveolar surface area of 0.34 m2. Modelled deposition rates
using MPPDep were estimated at 0.081 for the 1.3-Am DAE
mode (20% of aerosol mass), 0.047 for the 3.6-Am DAE
mode (35% of aerosol mass), and 0.000 for the 15-Am DAE
mode (45% of aerosol mass). Using these parameters, the
pulmonary compartment dose in the rats was estimated at 83
Ag, or 24 ng/cm2 alveolar surface area. Model assumptions
for a plausible human environmental exposure scenario
were an average tidal volume of 875 ml and an average
breathing frequency of 16 min 1 over the entire day,
oronasal breathing, and an alveolar surface area of 54 m2.endothelin system genes and h-actin in the lungs of naı¨ve Fischer-344 rats
er set, and all subsequent analyses were conducted at 25 cycles, ensuring
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urban particulate matter with size cut-off of 10-Am DAE
(PM10) containing a nucleation mode at 0.05-Am DAE (5%
of mass), a condensation mode at 0.2-Am DAE (25% of
mass) and coarse mode at 5-Am DAE (70% mass) were taken
as 0.20 for all modes [32]. Using these parameters, and
assuming a 24-h exposure to an average PM10 concentration
of 175 Ag/m3 [33], a reference pulmonary compartment
dose in humans was estimated as 706 Ag, or 1.3 ng/cm2
alveolar surface area.
Similarly, the peak centriacinar dose of ozone in the
lungs of rats (68 10 6 Ag of O3/cm2/h/Ag ambient O3/m3)
and humans (30 10 6 Ag of O3/cm2/h/Ag ambient O3/m3)
can be estimated by reference to biomathematical models
[34]. Exposure of our rats to 0.8 ppm ozone (1570 Ag of O3/
m3) over 4 h should have translated into a total centriacinar
peak dose of 427 ng of O3/cm
2. Exposure of a human
subject to 0.12 ppm ozone (236 Ag of O3/m3) for 12 h,
followed by 0.06 ppm ozone (118 Ag of O3/m3) for 12 h,
would lead to a total daily centriacinar peak dose estimated
at 127 ng of O3/cm
2 [29].
2.8. Statistical analyses
Expression data in pollutant-exposed animals at each of
the recovery time-points were expressed as the ratio of the
mean expression of treated animalsF S.E. over the time-
matched air-control mean. The control value for statistical
comparison was the aggregated data for all air control
animals at all time points (n = 30). The effect of treatment
on the expression of each gene of interest was then tested by
one-way ANOVA followed by Dunnett’s method to eluci-
date the pattern of significant effects, with a = 0.05 (Sigma-
Stat 2.0, SPSS Inc., Chicago, IL, USA).3. Results and discussion
PreproET-1 mRNA was elevated approximately 1.7-fold
(P < 0.05) 2 h after exposure to the pollutants (Fig. 2A).
Expression appeared to be reduced after recovery in clean
air for 24–48 h (P>0.05), consistent with the previous
observations by Ulrich et al. [25], but returned to control
levels by 72 h. Examination of gene expression over a
period of 2 weeks did not reveal sustained or delayed
modulation of ET-1 mRNA expression in the animals
exposed to the pollutants. ET-1 is produced from the
cleavage of the precursor peptide big ET-1 by ECE-1.
Inhalation of pollutants here also rapidly induced ECE-1
mRNA expression (P < 0.05) 2 h after exposure (Fig. 2B).
The upstream regions of the promoter sites of ECE-1 [35]
and ET-1 [36–38] share several regulatory factor motifs,
including AP-1/JUN-binding elements, acute phase respon-
sive elements, and NF-nB responsive motifs, and may
explain co-regulation of these two genes in our model.
The changes in regulation of ET-1 and ECE-1 are in linewith our previous observation of increased steady-state
plasma ET-1 following inhalation of urban particles [7,8],
and with the lungs being the principal source of circulating
ET-1 [14,39].
In contrast, preproET-3 mRNAwas decreased (P < 0.05)
2 h after exposure, returning to control values after 24-
h recovery of the animals in clean air (Fig. 2C). Interest-
ingly, this down-regulation of lung preproET-3 mRNA in
the present report does not correlate with the elevated
circulating ET-3 levels that have previously been docu-
mented in the plasma of rats between 2 and 48 h after
inhalation of urban particles [8]. Less is known about the
regulation of ET-3 and the source of the peptide in the
blood, but our present data indicate that elevation of plasma
ET-3 after inhalation of pollutants may not be due to
increased de novo synthesis in the lungs. In addition to
the lungs, ET-3 mRNA has been detected in the central
nervous system, kidney, small intestine, stomach, and spleen
[40]. The lungs, kidneys and liver are sites of ET-3 clearance
[19], and diseases involving these organs (e.g. liver cirrho-
sis) may be associated with increased plasma ET-3 [41].
Binding of ET-1 and ET-3 to the ETB receptors of
endothelial cells is a major pathway of clearance of the
circulating peptides [17,23], and ETB receptor density
appears to be controlled at the transcript level [17]. Impact
of the pollutants on endothelial ETB receptor expression
could therefore affect plasma levels of the endothelin
peptides. Binding of ET-1 to the ETA receptor of smooth
muscle cells leads to vasoconstriction and broncho-constric-
tion, and up-regulation of the ETA receptor in target cells of
the lungs could amplify the physiological impacts of the
activation of endothelin system genes after inhalation of
pollutants. We did not detect statistically significant changes
of ETA receptor (Fig. 2D) and ETB receptor (Fig. 2E)
expression over the period of 14 days after exposure to
the pollutants. However, because of the potential large
impact of slower clearance on the steady-state circulating
peptide levels, the small decrease of ETB receptor expres-
sion (P>0.05) seen at 24 h post-exposure warrants further
investigation. Site-specific analyses of micro-dissected sam-
ples using quantitative real-time RT-PCR, in situ PCR, or in
situ hybridization may be more sensitive to focal changes in
gene expression [42].
As with any biochemical changes, interpretation of
molecular data in the lungs during acute lung injury can
be confounded by the extensive cellular changes due to
epithelial and interstitial repair proliferation and inflamma-
tory infiltration in the septum and alveolar lumen. The
kinetics of repair and inflammation in rat lungs after an
acute injury is well established and is maximal between 24
and 48 h (for example, Refs. [43,44]). We report here clear
inductions of ET-1 and ECE-1 mRNA levels as early as 2
h after termination of exposure, prior to the maximum
inflammatory cell influx in the alveoli and interstitium,
and prior to epithelial and interstitial cell proliferation that
are known to occur 24–48 h after acute lung injury.
Fig. 2. Ratio of expression of the endothelin system genes in the lungs of pollutant-exposed rats over air control rats as reflected in the abundance of mRNA
and quantified by fluorimetric quantification of the RT-PCR products. Data are meanF S.E. for n= 30 (air controls, all time-points aggregated), n= 9 (2 h post-
exposure), and n= 3 (all other time-points). Data were analyzed by one-way ANOVA followed by Dunnett’s multiple comparison procedure (a= 0.05). (A)
Preproendothelin-1; 2 h post-exposure vs. air control, P < 0.05. (B) Endothelin converting enzyme-1; 2 h post-exposure vs. air control, P< 0.05. (C)
Preproendothelin-3; 2 h post-exposure vs. air control, P < 0.05. (D) Endothelin A receptor. (E) Endothelin B receptor.
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2 h post-exposure was likely due to up-regulation in
pulmonary cells rather than an import of the excess tran-
script by infiltrating inflammatory cells. Similarly, the
decrease of preproET-3 at 2 h post-exposure is unlikely to
have resulted from dilution of transcript levels after a large
influx of cells that do not express the peptide. The relative
contribution of inflammatory cells to the mRNA changes at
the 24–48-h time-points is not clear, but macrophages are
known to express and secrete ET-1 [7].In short, our findings verify that inhaled urban pollutants
up-regulate ET-1 and ECE-1 mRNA expression in the lungs,
and indicate that lung ET-1 and ET-3 are differentially
regulated at the transcript level by inhaled pollutants. It
remains possible that changes in circulating levels of ET-3
after inhalation of urban pollutants depend mainly on
reduced clearance rather that increased production by the
lungs, but direct data are lacking. To the best of our
knowledge, this is the first report of an acute impact of air
pollutant inhalation on gene expression of the potent bron-
Table 2
Ozone deposition model
Model parametersa Rat Humanb
Ozone concentration (ppm) 0.8 0.12 0.06
Ozone concentration (Ag/m3) 1570 236 118
Exposure (h) 4 12 12
Deposition ratec (10 6 Ag O3/cm2/h
per Ag O3/m3)
68 30 30
Centriacinar dose (ng O3/cm
2) 427 85 42
127d
Centriacinar dose rate (ng O3/cm2/h) 107 7.1 3.5
5.3e
a Model parameters from Ref. [29].
b Scenario is 12 h at 0.12 ppm O3 and 12 h at 0.06 ppm O3.
c Adapted from Ref. [34].
d Centriacinar dose (ng O3/cm
2) for 24 h.
e Average centriacinar dose-rate (ng O3/cm
2/h) over 24 h.
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lungs. The modulation of the pulmonary endothelinergic
system by inhaled pollutants may have profound human
health impacts. We have verified that human subjects
exposed to ozone and urban particulate matter exhibit a
constriction of the brachial artery [10], consistent with a
pressor effect of circulating ET-1 [8]. A recent study has
found that children in southwest metropolitan Mexico city
have 25% higher plasma ET-1 levels as compared to
children in low polluted areas [9]. The magnitude of this
change is known to be associated with an unfavourable
prognosis in congestive heart failure patients [45] or after
myocardial infarction [46]. Transcriptional activation of
preproET-1 and ECE-1 has been found to be linked with
chronic inflammation and may be important in atheroscle-
rotic plaque formation [47]. Repeated exposure to urban
pollutants and the resulting chronic inflammation and endo-
thelin system activation may therefore increase the likeli-
hood of plaque formation and enhance progression of
atherosclerosis in susceptible individuals [12]. It is note-
worthy that the response of the lung endothelinergic system
within a few hours of exposure of animals to the pollutants
in our study is in line with epidemiological evidence of
adverse cardiac effects in humans within 3 h after exposure
to occupational and ambient air pollutants [6].
Dosimetric relevance of the present experiment to an
environmental exposure should be evaluated after scaling
doses of pollutants within the lungs of rats and humans (see
Section 2.7 for calculations). The ratio of experimental dose
within the respiratory compartment of the rats (estimated at
24 ng particles/cm2 lung alveolar surface area) to the dose
calculated for a plausible human exposure scenario (esti-Table 1
Particle deposition model
Model parametersa Rat Human
Tidal volume (ml) 2.1 875
Breathing rate (min 1) 102 16
Inhalation nasal oronasal
Alveolar surface area (m 2) 0.34 54
Exposure (h) 4 24
Particle concentration (mg/m3) 49b 0.175c
Particle distribution assumption multimodal PM10
Mode 1 size (Am, DAE) 1.5 0.05
Mass fraction 0.20 0.05
Deposition rate 0.081 0.20d
Mode 2 size (Am, DAE) 3.6 0.2
Mass fraction 0.35 0.25
Deposition rate 0.047 0.20d
Mode 3 size (Am, DAE) 15 5
Mass fraction 0.45 0.70
Deposition rate 0.000 0.20d
Respiratory compartment dose (Ag) 83 706
Surface relative dose (ng/cm2) 24 1.3
Dose rate (ng/cm2/h) 6 0.05
a From Ref. [8] unless otherwise indicated.
b Particle concentration in present study.
c High-end average daily PM10 concentration in Mexico City [33].
d Alveolar deposition rates in human adapted from Ref. [32].mated at 1.3 ng particles/cm2) was only 18-fold (Table 1).
Similarly, the ratio of the centriacinar ozone dose in our
animals (427 ng O3/cm
2 alveolar duct surface area) to the
estimated internal dose in a human subject under a plausible
exposure scenario (127 ng O3/cm
2 alveolar duct surface
area) was only threefold (Table 2). For ethical reasons, nose-
only exposures should be kept to a minimum duration, and
therefore the dose-rate in our study was higher than for an
environmental exposure spread over a 24-h period. Never-
theless, the ratios of dose-rates for our animal-to-human
comparison were approximately 100-fold for particles, and
20-fold for ozone. From the standpoint of evaluation toxi-
cology, the internal depositions as well as the dose-rates of
the pollutants in the current study are relevant to human
exposures, once uncertainty factors are considered. These
include the possible decay of the potency of EHC-93 by
comparison to fresh particles, the known interspecies differ-
ences in sensitivity to air pollutants (with humans being
more responsive than rats [48,49]), and the inter-individual
differences in sensitivity within the human population (such
as increased sensitivity of individuals with congestive heart
failure or atherosclerosis [2,3,12]).4. Conclusion
In summary, we have shown that inhalation of common
urban pollutants in rats causes the coordinated elevation of
mRNA for preproET-1 and ECE-1. The observations are
consistent with previous reports of plasma ET-1 increases
following pollutant inhalation [7,8]. Elevation of ET-1 and
ECE-1 mRNA was early and transient, consistent with the
dynamics of urban pollutant health effects in the human
population, and indicated that regulation of the genes
preceded the known dynamics of inflammation and repair.
The combination of pollutants (ozone and urban particulate
matter) did not appear to result in sustained or delayed
regulation of ET-1 over 2 weeks post-exposure. While urban
particles are known to cause rapid and sustained increases of
E. Thomson et al. / Biochimica et Biophysica Acta 1689 (2004) 75–82 81ET-3 in rats [8], air pollutants in this report decreased lung
steady state mRNA levels for preproET-3. The data suggest
that the lungs may not be the source of the excess circulating
ET-3 after exposure to pollutants. Together, our data further
strengthen the biological evidence for the association be-
tween ambient air pollutants and increased acute cardiopul-
monary morbidity and mortality in the human population.Acknowledgements
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